ArticleJournal of cardiovascular translational research2026
Dynamic Evaluation of Vascular Remodeling and Aneurysm Progression Using Blood-Pool Contrast-Enhanced In Vivo Micro-CT in a Rodent Model.
Article in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Vascular graft remodeling and aneurysm progression are commonly studied in small animal models, but non-terminal methods for their assessment remain limited. This study evaluated contrast-enhanced micro-CT as a tool for longitudinal, in vivo monitoring of vascular grafts in rodents. Using a transplant model in which a pulmonary artery segment was implanted into the recipient's abdominal aorta, creating a pulmonary vascular graft, we compared a molecular iodinated contrast agent with a nanoparticle-based agent. The molecular agent was rapidly cleared, resulting in insufficient vascular opacification for graft visualization or quantification. In contrast, the nanoparticle agent provided prolonged vascular enhancement, enabling high-resolution imaging and quantitative assessment of graft morphology and aneurysm development over time. These findings demonstrate that contrast-enhanced micro-CT, particularly using nanoparticulate blood-pool contrast agents, enables a longitudinal, non-terminal evaluation of vascular grafts in rodents, enabling quantitative monitoring of graft remodeling, overcoming the limitations of traditional post-mortem, single timepoint analyses.
Indexed as
Identifiers
42593720What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.